Related references
Note: Only part of the references are listed.A Treatment-as-Prevention Trial to Eliminate Hepatitis C Among Men Who Have Sex With Men Living With Human Immunodeficiency Virus (HIV) in the Swiss HIV Cohort Study
Dominique L. Braun et al.
CLINICAL INFECTIOUS DISEASES (2021)
Reinfection With the Hepatitis C Virus in Men Who Have Sex With Men After Successful Treatment With Direct-acting Antivirals in Germany: Current Incidence Rates, Compared With Rates During the Interferon Era
Patrick Ingiliz et al.
CLINICAL INFECTIOUS DISEASES (2020)
The EuroSIDA study: 25 years of scientific achievements
K. Laut et al.
HIV MEDICINE (2020)
Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV
Samira Hosseini-Hooshyar et al.
AIDS (2020)
Reinfection by hepatitis C virus following effective all-oral direct-acting antiviral drug therapy in HIV/hepatitis C virus coinfected individuals
Juan Berenguer et al.
AIDS (2019)
Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy
Anne Boerekamps et al.
CLINICAL INFECTIOUS DISEASES (2018)
Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response After Sofosbuvir-Based Therapies
Christoph Sarrazin et al.
CLINICAL INFECTIOUS DISEASES (2017)
Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review
Sarah Larney et al.
LANCET GLOBAL HEALTH (2017)
Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIV
Jim Young et al.
CLINICAL INFECTIOUS DISEASES (2017)
Liver-related death among HIV/hepatitis C virus-co-infected individuals: implications for the era of directly acting antivirals
Daniel Grint et al.
AIDS (2015)
Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response
Bryony Simmons et al.
CLINICAL INFECTIOUS DISEASES (2015)
HIV and hepatitis C co-infection in Europe, Israel and Argentina: a EuroSIDA perspective
Lars Peters et al.
BMC INFECTIOUS DISEASES (2014)
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Nezam Afdhal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Rate and Timing of Hepatitis C Virus Relapse after a Successful Course of Pegylated Interferon plus Ribavirin in HIV-Infected and HIV-Uninfected Patients
Jose Medrano et al.
CLINICAL INFECTIOUS DISEASES (2009)
Share Paper
